Business of Cannabis: Berlin Executive Summit
November 26
Germany’s progressive stance on cannabis regulation has seen the country be at the forefront of the cannabis legalisation conversation in Europe for the last two years, fostering a rapidly growing market with significant potential. Already the largest medical cannabis market in Europe by way of sales and patient numbers, paired with the impending launch of a fully-regulated adult-use market, Germany is central to the European cannabis industry’s hopes for a bigger and brighter future.
The combined network of Business of Cannabis and Prohibition Partners is the largest B2B audience in the global cannabis industry, ensuring each summit attracts a diverse, and international audience of business leaders and key decision makers from a variety of industries.
The conference agenda will include a wide range of topics and themes to explore the current state of play and future outlook for the German adult-use and medical cannabis markets.